Effect of asoprisnil on the pharmacokinetics of triazolam and its metabolite in healthy female subjects.

被引：0
|
作者：
Lee, RD [1 ]
Mulford, D [1 ]
Witt, G [1 ]
Chwalisz, K [1 ]
机构：
[1] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.285
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P79 / P79
页数：1
相关论文
共 50 条
  • [1] Effect of ketoconazole and rifampin on the single dose pharmacokinetics of asoprisnil and its metabolite in healthy female subjects.
    Lee, RD
    Witt, G
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P49 - P49
  • [2] Effect of erythromycin on the pharmacokinetics of asoprisnil and its active metabolite J912 in healthy female subjects.
    Lee, RD
    Zhang, W
    Vernillet, L
    Andhivarothai, N
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P25 - P25
  • [3] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF ERTUGLIFLOZIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Liang, Y.
    Matschke, K.
    Shi, H.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [4] INDUCTIVE EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF VORICONAZOLE IN HEALTHY SUBJECTS.
    Lee, S.
    Shin, D.
    Kim, S.
    Ji, S. C.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Jang, I. J.
    Yu, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S3 - S4
  • [5] Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.
    Park, J
    Kim, K
    Jung, W
    Kim, S
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P34 - P34
  • [6] Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone in healthy subjects.
    Lebrun-Vignes, B
    Chosidow, O
    Diquet, B
    Levron, JC
    Herson, S
    Corbrion-Archer, V
    Puech, AJ
    Warot, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 683 - 683
  • [7] Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Lee, Y
    Orlowski, LH
    Michiels, N
    Petty, KJ
    Goldberg, MR
    Dru, J
    Chavez-Eng, CM
    Constanzer, M
    Murphy, G
    Gottesdiener, K
    Hesney, M
    Feuring, M
    Wehling, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P66 - P66
  • [8] EFFECT OF ACTIVATED CHARCOAL ON THE PHARMACOKINETICS OF APIXABAN IN HEALTHY SUBJECTS.
    Wang, X.
    Tirucherai, G.
    Pannacciulli, N.
    Wang, J.
    Elsrougy, A.
    Teslenko, V.
    Chang, M.
    Zhang, D.
    Frost, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S41 - S41
  • [9] PHARMACOKINETICS OF MAZINDOL AND ITS HYDROLYSIS METABOLITE AFTER ADMINISTRATION OF A SINGLE DOSE OF MAZINDOL CR IN HEALTHY SUBJECTS.
    Brantley, S.
    Hussey, B.
    Williams, R.
    Higgins, J.
    Schmith, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S48 - S49
  • [10] Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects
    Bruderer, Shirin
    Petersen-Sylla, Marc
    Boehler, Margaux
    Remenova, Tatiana
    Halabi, Atef
    Dingemanse, Jasper
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (12) : 2778 - 2788
12345